These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 25995170)

  • 1. The use of melatonin in Swedish children and adolescents--a register-based study according to age, gender, and medication of ADHD.
    Furster C; Hallerbäck MU
    Eur J Clin Pharmacol; 2015 Jul; 71(7):877-81. PubMed ID: 25995170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
    Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
    Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
    Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric Off-Label Use of Melatonin--A Register Linkage Study between the Norwegian Prescription Database and Patient Register.
    Hartz I; Handal M; Tverdal A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):267-73. PubMed ID: 25892306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Age, Gender, and Living Circumstances on Patterns of Attention-Deficit/Hyperactivity Disorder Medication Use in Children and Adolescents With or Without Intellectual Disabilities.
    Osunsanmi S; Turk J
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):828-834. PubMed ID: 26982546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.
    Sidorchuk A; Isomura K; Molero Y; Hellner C; Lichtenstein P; Chang Z; Franck J; Fernández de la Cruz L; Mataix-Cols D
    PLoS Med; 2018 Aug; 15(8):e1002635. PubMed ID: 30086134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High prevalence of treatment with ADHD medicines indicates overdiagnosis of ADHD in Iceland].
    Ingimarsson O; Gudbrandsdottir RK; Lauth BAM; Sigurdsson E
    Laeknabladid; 2024 Sep; 110(9):402-410. PubMed ID: 39221778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
    Garbe E; Mikolajczyk RT; Banaschewski T; Petermann U; Petermann F; Kraut AA; Langner I
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):452-8. PubMed ID: 23234588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric use of prescribed melatonin in Sweden 2006-2017: a register based study.
    Kimland EE; Bardage C; Collin J; Järleborg A; Ljung R; Iliadou AN
    Eur Child Adolesc Psychiatry; 2021 Sep; 30(9):1339-1350. PubMed ID: 32699990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
    Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
    Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting to Long-Term Effectiveness and Safety of Attention-deficit Hyperactivity Disorder Medications.
    Beau-Lejdstrom R; Zito JM
    Clin Pharmacol Ther; 2018 Oct; 104(4):610-612. PubMed ID: 30120774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of short term melatonin treatment in children with delayed Dim Light Melatonin Onset: effects on sleep, health, behavior problems, and parenting stress.
    van Maanen A; Meijer AM; Smits MG; Oort FJ
    Sleep Med; 2011 Oct; 12(9):875-9. PubMed ID: 21925946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sleep organization in patients with attention deficit hyperactivity disorder (ADHD) and ADHD as a comorbidity of epilepsy.
    Kalil Neto F; Nunes ML
    Sleep Med; 2017 May; 33():91-96. PubMed ID: 28449914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.
    Gringras P; Gamble C; Jones AP; Wiggs L; Williamson PR; Sutcliffe A; Montgomery P; Whitehouse WP; Choonara I; Allport T; Edmond A; Appleton R;
    BMJ; 2012 Nov; 345():e6664. PubMed ID: 23129488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and profiles of methylphenidate use both in children and adults.
    Pauly V; Frauger E; Lepelley M; Mallaret M; Boucherie Q; Micallef J
    Br J Clin Pharmacol; 2018 Jun; 84(6):1215-1227. PubMed ID: 29512177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.